steatoblepharon

steatoblepharon

(stē″ă-tŏ-blef′ă-ron″) [ steato- + blepharo-]
The prolapse of fat from the orbit of the eye below the eyelid. The condition is often associated with dermatochalasis (sagging of eyelid tissues).
References in periodicals archive ?
In April it acquired Topokine Therapeutics, a clinical-stage biotech focused on topical medicines for fat reduction, for $85 million upfront, gaining XAF5, a topical agent in late-stage development for the treatment of steatoblepharon (undereye bags).
Under the terms of the agreement, Allergan acquired Topokine Therapeutics for an upfront payment of USD 85m and success-based development and sales milestones for XAF5, a first-in-class topical agent in late-stage development for the treatment of steatoblepharon, also known as undereye bags.
The acquisition expands Allergan's cosmetic drugs pipeline with Topokines Phase IIb/III candidate XAF5, a prospective first-in-class topical treatment for steatoblepharon, or bags under the eyes.